BRIEF-Spero Therapeutics initiates clinical program for SPR994
October 20, 2017 at 08:17 AM EDT
* Spero Therapeutics initiates clinical program for oral carbapenem SPR994
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.